ARRIVA DURHAM COUNTY LIMITED

Comprehensive Financial Health Assessment: ARRIVA DURHAM COUNTY LIMITED

1. Financial Health Score: B (Incomplete Data / Stable Structural Condition)

Explanation: Without the specific financial metrics (revenue, profit, cash position) that typically act as the "blood work" for a corporate health assessment, a definitive financial grade cannot be given. However, based on the corporate and compliance "vital signs" available, the company scores a solid B. The patient is alive, active, and fully compliant with regulatory requirements, showing no immediate external symptoms of distress.

2. Key Vital Signs

• Corporate Pulse (Status & Age): Active & Established – Incorporated in 1989, this business has a 35-year track record. In medical terms, this is a mature patient with a long medical history. The "Active" status confirms a steady heartbeat; the company is currently operational and not in administration or liquidation.
• Compliance Blood Pressure: Optimal – The company’s filing records show no signs of hypertension or distress. Accounts are up to date (made up to 31 Dec 2024) and not overdue. The Confirmation Statement is also filed up to 2026 with no overdue flags. Healthy compliance blood pressure indicates that the company is not suffering from the administrative neglect that often precedes corporate failure.
• Genetic Lineage (Ownership & Capital): Subsidiary Status – The company is wholly owned by Arriva Uk Bus Holdings Limited (which holds more than 75% of voting rights). The share capital is a nominal £1,001. Do not be alarmed by this low number; in a subsidiary, this is simply the corporate DNA linking it to the parent. Its financial health is intrinsically tied to the "parent organism" (the wider Arriva Group).
• Boardroom Immunology (Director Changes): Fluctuating – There have been recent changes to the board of directors, with three resignations recorded in late 2025 (Nicholas John Bradley, Ben William SCOTT, Kimberley Jayne CAIN). While routine changes in a subsidiary's board are common—often reflecting group-wide restructuring rather than individual company illness—sudden shifts in the "immune system" warrant observation to ensure continuity of strategic direction.
• Missing Lab Results (Financial Metrics): – Critical vital signs such as Fixed Assets, Current Assets, Net Current Assets (working capital), and Shareholders' Funds are not present in the current chart. Without these, we cannot measure the company's cholesterol (debt levels) or blood sugar (cash flow).

3. Diagnosis

Based on the available data, Arriva Durham County Limited presents as a structurally sound, long-standing subsidiary operating within the wider Arriva Group. The absence of overdue filings or legal distress (administration, liquidation) means there are no immediate, visible symptoms of terminal corporate illness.

However, the recent multiple director resignations could be symptomatic of a broader corporate reorganization, a change in strategic direction, or simply routine group portfolio management. Because this is an "Audit Exemption Subsidiary," it benefits from group accounting provisions, meaning its own standalone financials might not tell the whole story of its health anyway—it relies on the financial circulatory system of its parent company.

Ultimately, without the detailed P&L and balance sheet data, the internal financial health—profitability, liquidity, and solvency—remains undiagnosed.

4. Recommendations

• Order Full Blood Work: To accurately diagnose financial wellness, the latest filed annual accounts (containing the balance sheet and profit & loss reserves) must be retrieved and reviewed. This will reveal whether the company is generating healthy cash flow or bleeding capital.
• Monitor the Immune System: Keep a close eye on the board composition following the late-2025 resignations. Ensure that new directors are appointed promptly to maintain corporate governance and that operational continuity is not disrupted during the transition.
• Check the Parent's Heartbeat: Because the company is controlled by Arriva Uk Bus Holdings Limited, a true diagnosis of this company's future health requires checking the financial stability and strategic intentions of the parent group. A subsidiary is only as healthy as the parent organism supporting it.
• Review Industry Health: Operating in SIC code 49319 (urban passenger land transport), the company is subject to public contracts, fuel price fluctuations, and shifting commuter habits. A full check-up should assess external market factors impacting the UK bus transport sector.